JAK;JAK
JAK3;Janus, kinase, 3;L-JAK;JAKL;LJAK;JAK3_HUMAN;JAK-3;Tyrosine-protein, kinase, JAK3;Janus, kinase, 3;Leukocyte, janus, kinase
MICA;MHC, class, I, polypeptide-related, sequence, A;PERB11.1;MHC, class, I, polypeptide-related, sequence, A
MICB;MHC, class, I, polypeptide-related, sequence, B;PERB11.2;MHC, class, I, polypeptide-related, sequence, B
MICC;MHC, class, I, polypeptide-related, sequence, C, (pseudogene);MHC, class, I, polypeptide-related, sequence, C;PERB11.3
ORF6;ORF6
ORF8;ORF8
IMPα;IMPα
IMPβ1;IMPβ1
IPO4;importin, 4;Imp4;FLJ23338;Importin-4;Importin-4b;Ran-binding, protein, 4
IPO5;importin, 5;KPNB3;RANBP5;karyopherin, (importin), beta, 3;RAN, binding, protein, 5;IMB3;MGC2068;PSE1;Importin-5;Importin, subunit, beta-3;Karyopherin, beta-3;Ran-binding, protein, 5
IPO5P1;importin, 5, pseudogene, 1
NMI;N-myc, and, STAT, interactor;N-myc, (and, STAT), interactor;N-myc-interactor;N-myc, and, STAT, interactor
PIAS1;protein, inhibitor, of, activated, STAT, 1;DDXBP1;DEAD/H, (Asp-Glu-Ala-Asp/His), box, binding, protein, 1;GBP;GU/RH-II;ZMIZ3;E3, SUMO-protein, ligase, PIAS1;DEAD/H, box-binding, protein, 1;E3, SUMO-protein, transferase, PIAS1;Gu-binding, protein;Protein, inhibitor, of, activated, STAT, protein, 1;RNA, helicase, II-binding, protein
PIAS2;protein, inhibitor, of, activated, STAT, 2;PIASX-BETA;miz;PIASX-ALPHA;ZMIZ4;ARIP3;E3, SUMO-protein, ligase, PIAS2;Androgen, receptor-interacting, protein, 3;DAB2-interacting, protein;E3, SUMO-protein, transferase, PIAS2;Msx-interacting, zinc, finger, protein;PIAS-NY, protein;Protein, inhibitor, of, activated, STAT, x;Protein, inhibitor, of, activated, STAT2
PIAS3;protein, inhibitor, of, activated, STAT, 3;FLJ14651;ZMIZ5;E3, SUMO-protein, ligase, PIAS3;E3, SUMO-protein, transferase, PIAS3;Protein, inhibitor, of, activated, STAT, protein, 3
PIAS4;protein, inhibitor, of, activated, STAT, 4;Piasg;PIASY;FLJ12419;ZMIZ6;E3, SUMO-protein, ligase, PIAS4;PIASy;Protein, inhibitor, of, activated, STAT, protein, 4;Protein, inhibitor, of, activated, STAT, protein, gamma
STAT;STAT
ACE2;angiotensin, converting, enzyme, 2;angiotensin, I, converting, enzyme, (peptidyl-dipeptidase, A), 2;angiotensin, I, converting, enzyme, 2;ACEH;Angiotensin-converting, enzyme, 2;Angiotensin-converting, enzyme, homolog;Angiotensin-converting, enzyme-related, carboxypeptidase;Metalloprotease, MPROT15;Processed, angiotensin-converting, enzyme, 2
CD4;CD4, molecule;CD4, antigen, (p55);T-cell, surface, glycoprotein, CD4;T4;Leu-3;T-cell, surface, antigen, T4/Leu-3
CD4+;CD4+
CD8A;CD8, subunit, alpha;CD8;CD8, antigen, ',', alpha, polypeptide, (p32);T-cell, surface, glycoprotein, CD8, alpha, chain;CD8a, molecule;p32;CD8alpha;T-lymphocyte, differentiation, antigen, T8/Leu-2
CD8B;CD8, subunit, beta;CD8B1;CD8, antigen, ',', beta, polypeptide, 1, (p37);CD8b, molecule;Ly-3;LYT3;P37;CD8beta;T-cell, surface, glycoprotein, CD8, beta, chain
CD8+;CD8+
CCR5;C-C, motif, chemokine, receptor, 5;CMKBR5;chemokine, (C-C, motif), receptor, 5;chemokine, (C-C, motif), receptor, 5, (gene/pseudogene);C-C, motif, chemokine, receptor, 5, (gene/pseudogene);CKR-5;CC-CKR-5;CKR5;CD195;IDDM22;C-C, chemokine, receptor, type, 5;CHEMR13;HIV-1, fusion, coreceptor
CXCR4;C-X-C, motif, chemokine, receptor, 4;chemokine, (C-X-C, motif), ',', receptor, 4, (fusin);chemokine, (C-X-C, motif), receptor, 4;LESTR;NPY3R;HM89;NPYY3R;D2S201E;fusin;HSY3RR;NPYR;CD184;C-X-C, chemokine, receptor, type, 4;FB22;Fusin;LCR1;Leukocyte-derived, seven, transmembrane, domain, receptor;Lipopolysaccharide-associated, protein, 3;NPYRL;Stromal, cell-derived, factor, 1, receptor
PSMB7;proteasome, 20S, subunit, beta, 7;proteasome, (prosome, ',', macropain), subunit, ',', beta, type, ',', 7;proteasome, subunit, beta, 7;Z;Proteasome, subunit, beta, type-7;Macropain, chain, Z;Multicatalytic, endopeptidase, complex, chain, Z;Proteasome, subunit, Z
SARS-CoV-2;SARS-CoV-2
C17orf49;chromosome, 17, open, reading, frame, 49;MGC49942;BAP18;HEPIS;Chromatin, complexes, subunit, BAP18;BPTF-associated, protein, of, 18, kDa
SARS-CoV;SARS-CoV
HLA-A;major, histocompatibility, complex, ',', class, I, ',', A;HLA, class, I, histocompatibility, antigen, ',', A, alpha, chain;Human, leukocyte, antigen, A
PRRC2B;proline, rich, coiled-coil, 2B;KIAA0515;BAT2L;BAT2L1;KIAA0515;HLA-B, associated, transcript, 2-like;HLA-B, associated, transcript, 2-like, 1;proline-rich, coiled-coil, 2B;MGC10526;LQFBS-1;Protein, PRRC2B;HLA-B-associated, transcript, 2-like, 1;Proline-rich, coiled-coil, protein, 2B
HLA-B;HLA-B
PPP1R10;protein, phosphatase, 1, regulatory, subunit, 10;protein, phosphatase, 1, ',', regulatory, (inhibitor), subunit, 10;protein, phosphatase, 1, ',', regulatory, subunit, 10;PNUTS;FB19;CAT53;p99;Serine/threonine-protein, phosphatase, 1, regulatory, subunit, 10;MHC, class, I, region, proline-rich, protein, CAT53;PP1-binding, protein, of, 114, kDa;Phosphatase, 1, nuclear, targeting, subunit;Protein, FB19
HLA-C;HLA-C
;
